Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EUGMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New PatientCentered Offerings
News Source : Financial Post
News Summary
- Tilray Craft cannabis is cultivated and produced indoors at Tilray’s EU‑GMP certified facility located in Neumünster, Germany.
- The production process adheres to rigorous quality control standards and protocols, ensuring distinctive, quality medical cannabis that patients can depend on for consistency and reliability.
- All Tilray Craft products are available by prescription at pharmacies throughout Germany.
- For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow us on social platforms.
Tilray Brands, Inc.(Tilray) (Nasdaq TLRY; TSX TLRY), is a leading global lifestyle and consumer packaged goods company with operations inCanada,the United States,Europe,Australia, New Zealand [+2935 chars]
Never miss a story from us, subscribe to our newsletter